Dynavax Technologies
DVAX
#5493
Rank
S$1.66 B
Marketcap
S$14.18
Share price
-0.09%
Change (1 day)
-18.10%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : S$0.69 Billion

According to Dynavax Technologies 's latest financial reports the company has S$0.69 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.81 B-1.26%
2023-12-31$S$0.82 B5.48%
2022-12-31$S$0.77 B159.09%
2021-12-31$S$0.30 B287.17%
2020-12-31$S$77.64 M594.74%
2019-12-31$S$11.17 M-87.03%
2018-12-31$S$86.15 M-67.72%
2017-12-31$S$0.26 B106.74%
2016-12-31$S$0.12 B-51.21%
2015-12-31$S$0.26 B99.31%
2014-12-31$S$0.13 B-43.75%
2013-12-31$S$0.23 B68.09%
2012-12-31$S$0.14 B8.56%
2011-12-31$S$0.12 B92.7%
2010-12-31$S$67.12 M649.9%
2009-12-31$S$8.95 M-61.26%
2008-12-31$S$23.1 M-58.97%
2007-12-31$S$56.3 M-53.56%
2006-12-31$S$0.12 B-2.07%
2005-12-31$S$0.12 B26.75%
2004-12-31$S$97.68 M-200.52%
2003-12-31$-S$97.19 Million-0.65%
2002-12-31$-S$97.82 Million53.52%
2001-12-31$-S$63.72 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-S$0.37 Billion-152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$23.56 B 3,308.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$67.17 B 9,617.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$27.76 B 3,916.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$59.49 B 8,506.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
S$27.40 B 3,864.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$120.48 B 17,329.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$9.38 B 1,258.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
S$12.44 B 1,700.85%๐Ÿ‡บ๐Ÿ‡ธ USA